WallStreetZenWallStreetZen

NASDAQ: VKTX
Viking Therapeutics Inc Stock Ownership - Who owns Viking Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Viking Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Greg ZanteChief Financial Officer2026-01-051,500$32.09
$48.13kSell
Brian LianPresident CEO2026-01-05132,454$32.29
$4.28MSell
Brian LianPresident CEO2026-01-0553,279$33.38
$1.78MSell
Brian LianPresident CEO2026-01-0541,276$34.22
$1.41MSell
Brian LianPresident CEO2026-01-056,400$35.07
$224.42kSell
Marianna ManciniChief Operating Officer2026-01-0531,961$32.29
$1.03MSell
Marianna ManciniChief Operating Officer2026-01-0513,600$33.37
$453.87kSell
Marianna ManciniChief Operating Officer2026-01-0510,500$34.22
$359.30kSell
Marianna ManciniChief Operating Officer2026-01-051,600$35.07
$56.12kSell
Greg ZanteChief Financial Officer2026-01-0531,961$32.30
$1.03MSell

1 of 3

VKTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VKTX insiders and whales buy or sell their stock.

VKTX Shareholders

What type of owners hold Viking Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc8.85%9,999,107$262.88MInstitution
Ligand Pharmaceuticals Inc5.15%5,819,383$152.99MInsider
Fmr LLC5.12%5,790,051$152.22MInstitution
Blackrock Inc4.95%5,596,166$147.12MInstitution
State Street Corp3.99%4,513,832$118.67MInstitution
Morgan Stanley3.30%3,729,117$98.04MInstitution
Jpmorgan Chase Co2.28%2,577,087$67.75MInstitution
Brian Lian2.21%2,499,291$65.71MInsider
Susquehanna International Group LLP1.86%2,099,564$55.20MInstitution
Ameriprise Financial Inc1.85%2,092,840$55.02MInstitution

1 of 3

VKTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VKTX63.02%9.09%Net SellingNet Selling
XENE97.16%2.84%Net SellingNet Selling
KNSA53.90%9.37%Net SellingNet Selling
LEGN22.65%0.00%
CNTA90.10%9.90%Net BuyingNet Selling
View Top Biotech Stocks

Viking Therapeutics Stock Ownership FAQ

Who owns Viking Therapeutics?

Viking Therapeutics (NASDAQ: VKTX) is owned by 63.02% institutional shareholders, 9.09% Viking Therapeutics insiders, and 27.90% retail investors. Ligand Pharmaceuticals Inc is the largest individual Viking Therapeutics shareholder, owning 5.82M shares representing 5.15% of the company. Ligand Pharmaceuticals Inc's Viking Therapeutics shares are currently valued at $165.50M.

If you're new to stock investing, here's how to buy Viking Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.